A Phase 2 randomized proff of concept study of Nab-Paclitaxel/Gemcitabine alone and in combination with ACP-196 in subjects with previously untreated metastatic pancreatic cancer.

Administered By

Contributors

Start/End

  • November 1, 2015 - October 19, 2017